TrialFluids and barriers of the CNS2017

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency.

Edit Dósa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.